Bar Coding Should Begin With Eight “High Priority” Products, HDMA Says
The Healthcare Distribution Management Association is recommending that eight "high-risk, high-priority" drugs be the first targets for bar coding
You may also be interested in...
FDA's pharmaceutical bar coding final rule has a shorter implementation timeline than the agency previously proposed
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials